Investors challenge new GSK chief’s pay deal

Posted on by

Leading shareholders in GlaxoSmithKline (GSK), Britain’s biggest drugs company, are piling pressure on its board to reduce a proposed multi-million pound pay deal for Emma Walmsley, its new chief executive.
Source: Sky Business News